News Room

Shanghai FTZ Fund invests in PCR enterprise Bioer Technology Co., Ltd.

2020-07-10

Recently, Shanghai FTZ Fund invested in Bioer Technology Co., Ltd. (BIOER), a leading enterprise in PCR industry in China. BIOER is mainly engaged in the R&D, manufacturing, sales and service of nucleic acid detection instruments and reagents, focusing on the PCR field for more than 25 years.

SHFTZFUND won multiple awards including ‘PEAS Best Investment Institution’ in 2023.

Shanghai FTZ Fund successfully holds the "Lingang Industry Salon" for Spatial Information Industry

This activity is a brand series of activities held by Shanghai FTZ Fund and its Lingang Special Area Sci-tech Innovation Fund on a regular basis.

Shanghai FTZ Fund receives China Bridge 2023 Annual Awards

Lately, Shanghai FTZ Fund has been awarded China Bridge "2023 Top 50 Private Equity Investment Institutions in China" and "2023 Best Chinese Capital Investment Institution".

Shanghai FTZ Fund awarded ZERO2IPO 2023 "Chinese State-owned Capital Investment Institutions Top50"

Today, ZERO2IPO published "China Venture Capital & Private Equity Annual Ranking 2023", and Shanghai FTZ Fund has been awarded 2023 "Chinese State-owned Capital Investment Institutions Top50"

Shanghai FTZ Fund
Wechat Official Account